Octreotide treatment of patients with hepatocellular carcinoma - a retrospective single centre controlled study

BACKGROUND: Studies of treatment with octreotide of patients with hepatocellular carcinoma (HCC) gave conflicting results. We analyzed retrospectively the survival of our patients treated with octreotide monotherapy and compared it to stage-matched patients who received either TACE, multimodal thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Schöniger-Hekele, Maximilian, Kettenbach, Joachim, Peck-Radosavljevic, Markus, Müller, Christian
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779805/
https://www.ncbi.nlm.nih.gov/pubmed/19887008
http://dx.doi.org/10.1186/1756-9966-28-142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779805/
https://www.ncbi.nlm.nih.gov/pubmed/19887008
http://dx.doi.org/10.1186/1756-9966-28-142

Ejemplares similares